Home » Topics » BioWorld Science, Endocrine/metabolic

BioWorld Science, Endocrine/metabolic
RSS

Novel agents for treating diabetes and related complications disclosed in recent patents

March 3, 2006

Pfizer acquires sanofi-aventis' rights to Exubera

March 3, 2006

Apidra now available to treat hyperglycemia in diabetes patients

March 2, 2006

OrthoLogic forms alliance with Quintiles for Chrysalin

March 2, 2006

rhCD59-P represents a novel approach for PNH therapy

March 2, 2006

New phase II study to evaluate MF-101 for menopausal symptoms

March 2, 2006

DPP-IV inhibitor GRC-8200 well tolerated in phase I study

March 1, 2006

PC-DAC:Exendin-4 cleared for phase I/II study in type 2 diabetes

March 1, 2006

Phase II trial assesses cortisol synthesis inhibitor DIO-902 for type 2 diabetes

Feb. 28, 2006

Phase I study assesses safety of gene therapy product AGTC-0106

Feb. 28, 2006

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 19, 2026.
ASGCT 2026: Directed evolution in gene therapy
BioWorld
Directed evolution has become a central pillar in gene therapy. This engineering strategy enables the generation of more efficient variants of genetic editors and...
News in brief
BioWorld Asia
BioWorld Asia briefs for May 19, 2026
Authorities work to quickly sequence Ebola species in latest outbreak
BioWorld
If the recent hantavirus outbreak wasn’t enough to keep public health officials busy, a new Ebola virus disease outbreak has been confirmed by authorities in the...
NTX-819, a novel mGlu7 NAM for psychiatric disorders
BioWorld Science
Increasing evidence supports metabotropic glutamate mGlu7 receptor as a promising target in psychiatric disorders. Neurosterix Pharma Sarl has presented data on...